Rafael Luiz Pereira

Rafael Luiz Pereira

Auto-generated profile, based on publicly available information

Rafael Luiz Pereira

Federal University of Paraná, Department of Physiology, Curitiba, State of Paraná, Brazil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Kidney International
Verified
Journal Article
Closed access
RPRafael L. Pereira
Rafael L. Pereira
BBBruna N. Buscariollo
Bruna N. Buscariollo
MCMatheus Corrêa-Costa
Matheus Corrêa-Costa
PSPatricia Semedo
Patricia Semedo
COCassiano D. Oliveira
Cassiano D. Oliveira
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara

12 March 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RPRafael L Pereira
Rafael L Pereira
VRVanessa O Reis
Vanessa O Reis
PSPatricia Semedo
Patricia Semedo
BBBruna N Buscariollo
Bruna N Buscariollo
CDCassiano Donizetti-Oliveira
Cassiano Donizetti-Oliveira
AKAlexandre C Keller
Alexandre C Keller
A growing body of evidence demonstrates a correlation between Th2 cytokines and the development of focal and segmental glomerulosclerosis (FSGS). Therefore, we hypothesized that GSL-1, a monoglycosylceramide from Sphingomonas ssp. with pro-Th1 activity on invariant Natural Killer T (iNKT) lymphocytes, could counterbalance the Th2 profile and modulate glomerulosclerosis. Using an adriamycin(ADM)-based model of FSGS, we found that BALB/c mice presented albuminuria and glomerular degeneration in association with a Th2-like pro-fibrogenic profile; these mice also expressed a combination of inflammatory cytokines, such as IL-4, IL-1α, IL-1β, IL-17, TNF-α, and chemokines, such as RANTES and eotaxin. In addition, we observed a decrease in the mRNA levels of GD3 synthase, the enzyme responsible for GD3 metabolism, a glycolipid associated with podocyte physiology. GSL-1 treatment inhibited ADM-induced renal dysfunction and preserved kidney architecture, a phenomenon associated with the induction of a Th1-like response, increased levels of GD3 synthase transcripts and inhibition of pro-fibrotic transcripts and inflammatory cytokines. TGF-β analysis revealed increased levels of circulating protein and tissue transcripts in both ADM- and GSL-1-treated mice, suggesting that TGF-β could be associated with both FSGS pathology and iNKT-mediated immunosuppression; therefore, we analyzed the kidney expression of phosphorylated SMAD2/3 and SMAD7 proteins, molecules associated with the deleterious and protective effects of TGF-β, respectively. We found high levels of phosphoSMAD2/3 in ADM mice in contrast to the GSL-1 treated group in which SMAD7 expression increased. These data suggest that GSL-1 treatment modulates the downstream signaling of TGF-β through a renoprotective pathway. Finally, GSL-1 treatment at day 4, a period when proteinuria was already established, was still able to improve renal function, preserve renal structure and inhibit fibrogenic transcripts. In conclusion, our work demonstrates that the iNKT agonist GSL-1 modulates the pathogenesis of ADM-induced glomerulosclerosis and may provide an alternative approach to disease management.

1 January 2014 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
RPRafael Luiz Pereira
Rafael Luiz Pereira
RFRaphael Jose Ferreira Felizardo
Raphael Jose Ferreira Felizardo
MCMarcos Antônio Cenedeze
Marcos Antônio Cenedeze
MHMeire Ioshie Hiyane
Meire Ioshie Hiyane
ÊBÊnio Bassi
Ênio Bassi
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara
Focal and segmental glomerulosclerosis (FSGS) is one of the most important renal diseases related to end stage renal failure. Bradykinin has been implicated in the pathogenesis of renal inflammation whereas the role of its receptor 2 (B2RBK) in FSGS has not been studied. FSGS was induced in wild type and B2RBK KO mice by a single intravenous injection of Adriamycin (ADM). In order to further modulate the kinin receptors, animals were also treated with B2RBK antagonist HOE-140, and DALBK, B1RBK antagonist. Here, we show that the blockage of B2RBK with HOE-140 protects mice from FSGS development, including podocyte foot process effacement and reestablishment of slit diaphragm-related proteins. However, B2RBK KO mice were not protected from FSGS. These opposite results were due to B1RBK expression. B1RBK was up regulated after ADM injection and it was exacerbated in B2RBK KO animals. Further, HOE-140 treatment down regulated B1RBK receptor. The blockade of B1RBK in B2RBK KO animals promoted FSGS regression, with a less inflammatory phenotype. These results indicate a deleterious role of both kinin receptors in FSGS model and suggest a possible crosstalk of them in disease progression.

6 October 2022 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
TSThabata Caroline de Oliveira Santos
Thabata Caroline de Oliveira Santos
GPGabriel Pereira
Gabriel Pereira
ACAnna Gabrielle Gomes Coutinho
Anna Gabrielle Gomes Coutinho
HSHalison Pereira Dos Santos Silva
Halison Pereira Dos Santos Silva
MLMarcelo M S Lima
Marcelo M S Lima
RPRafael Luiz Pereira
Rafael Luiz Pereira

20 July 2022 in Magna Scientia UCEVA
Verified
Journal Article
Open access
PDF file
MRMaria Augusta Ruy-Barbosa
Maria Augusta Ruy-Barbosa
ESEmily Pereira dos Santos
Emily Pereira dos Santos
GPGabriel Pereira
Gabriel Pereira
SASofía Tomaselli Arioni
Sofía Tomaselli Arioni
TSThabata Caroline de Oliveira Santos
Thabata Caroline de Oliveira Santos
RPRafael Luiz Pereira
Rafael Luiz Pereira
The aim of this study was to conduct a systematic review in order to evaluate the main effects of intradialytic physical exercise on different parameters of functional capacity in dialytic patients. The clinical question that guided the objective of this study was developed using the PICO method (Population, Intervention, Comparation and Outcome)." Where i) population: patients on hemodialysis; ii) intervention: physical exercise; iii) comparison: active vs sedentary patients; and iv) outcome: functional capacity. The combinations of the following keywords were used: CKD, physical exercise, exercise, physical training and hemodialysis. The selection of studies was performed using the PubMed database and only studies dating from 2011 to 2021 were selected. The search results led to 53 studies. The following steps were carefully analyzed, such as the title, abstract and the full paper description to evaluate whether they met the following inclusion criteria: i) target audience of the studies should be patients on hemodialysis; ii) outcomes that analyze different parameters of functional capacity; iii) Intervention using physical exercise; and iii) intradialytic exercise. The final results indicate that intradialytic physical exercise can cause significant changes in the evaluated outcomes of functional capacity, such as increased strength, improvement of cardiorespiratory function, and improvement of locomotor activity. It was concluded that intradialytic training protocols should be encouraged in clinical practices because they are responsible for causing beneficial changes in the functional capacity of hemodialytic patients.

13 April 2026 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
GPGabriel Pereira
Gabriel Pereira
TSThabata Caroline de Oliveira Santos
Thabata Caroline de Oliveira Santos
SASofía Tomaselli Arioni
Sofía Tomaselli Arioni
PSPietra Mancini Seibt
Pietra Mancini Seibt
ESEmily Pereira dos Santos
Emily Pereira dos Santos
RPRafael Luiz Pereira
Rafael Luiz Pereira
Current evidence show that exercise has beneficial effects on skeletal muscle function in individuals with chronic kidney disease (CKD). The STAT3 signaling pathway and the apelin axis (apelin receptor, APLNR- and ligands, -apelin and/or -elabela), participate in the processes of kidney inflammation and fibrosis and both may be involved in muscle wasting during CKD. Herein we report that STAT3 pathway and APLNR are in fact involved in the muscle impairment concomitant to CKD in experimental model and in adult individuals with CKD. Male BALB/c mice were first submitted to an 8-week ladder climbing resistance training (RT) protocol and further were submitted to doxorubicin-induced experimental CKD with or without use of the STAT3 inhibitor (Stattic). The GSE157712 dataset was used to assess the muscle transcriptome profile of CKD patients. Bioinformatics' analysis of gene set enrichment analysis (GSEA) and gene ontology (GO) were performed and the APLNR was found to be a central component of muscle response over kidney stress. Mice from the RT protocol showed a protective effect of blocking STAT3 against kidney and muscle injury markers, while both CKD individuals and CKD mice reported alterations in the APLNR muscle expression. In conclusion, the muscle tissue function is affected during CKD, which can be attenuated by a protective and synergistic effect of exercise and STAT3 inhibition. Thus, APLNR appears as a key gene associated with muscle dysfunction in CKD patients and its muscle expression can be regulated by resistance exercise.